alpha-Neu5Ac-(2->3)-beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer
alpha-neu5ac-(2->3)-beta-d-galp-(1->3)-beta-d-galpnac-(1->3)-alpha-d-galp-(1->4)-beta-d-galp-(1->4)-beta-d-glcp-(1<->1')-cer
A glycotetraosylceramide having <em>N</em>-acetyl-β-<small>D</small>-neuraminyl-(2→3)-β-<small>D</small>-galactosyl-(1→3)-<em>N</em>-acetyl-β-<small>D</small>-galactosaminyl-(1→3)-α-<small>D</small>-galactosyl-(1→4)-β-<small>D</small>-galactosyl-(1→4)-β-<small>D</small>-glucose as the hexasaccharide component. It is overexpressed in some cancers and has been linked to disease progression.